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163 Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of
myectomy
Manuela Jo¨rg-Ciopor, MD, Mehdi Namdar, MD, Jurai Turina, MD, Rolf Jenni, MD, MSEE,
Ju¨rg Schwitter, MD, Marko Turina, MD, Otto M. Hess, MD, and Philipp A. Kaufmann, MD,
Berne and Zu¨rich, Switzerland
Fifteen controls and 22 patients with hypertrophic cardiomyopathy (HCM) underwent PET for
assessment of myocardial perfusion and coronary flow reserve (CFR). CFR was reduced in
patients with HCM versus controls. Septal CFR was higher in patients with HCM treated
surgically (37%, P  .01) versus patients with HCM treated medically, suggesting that
myectomy may improve septal CFR in HCM.
170 Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Albert J. Chong, MD, Akira Shimamoto, MD, PhD, Craig R. Hampton, MD, Hiroo Takayama,
MD, Denise J. Spring, PhD, Christine L. Rothnie, BS, Masaki Yada, MD, Timothy H. Pohlman,
MD, and Edward D. Verrier, MD, Seattle, Wash, and Tsu, Japan
We studied the role of toll-like receptor 4 (TLR4) and its signaling mechanisms in a murine
model of myocardial ischemia/reperfusion injury. Functional mutation of TLR4 resulted in an
attenuation of myocardial infarct size; a decrease in activation of JNK, NF-B, and AP-1; and
a reduction in mRNA expression of inflammatory mediators.
180 Nitric oxide attenuates cardiomyocytic apoptosis via diminished
mitochondrial complex I up-regulation from cardiac ischemia-reperfusion
injury under cardiopulmonary bypass
Chi-Hsiao Yeh, MD, Yu-Min Lin, Yi-Cheng Wu, MD, Yao-Chang Wang, MD, and
Pyng Jing Lin, MD, Taoyuan, Taiwan
NO-enriched cardioplegic solutions may inhibit the mitochondrial pathway of apoptosis by
prevention of the NADH:ubiquinone oxidoreductase up-regulation and diminished postischemic
cardiomyocytic apoptosis after global cardiac arrest under CPB, which could preserve the
postischemic myocardial contractility.
The Journal of
Thoracic and
Cardiovascular
Surgery
Vol 128, No. 2, August 2004
Table of Contents
(continued on page 8A)
The Journal of Thoracic and Cardiovascular Surgery ● Volume 128, Number 2 7A
CS
P
G
TS
A
CD
CP
C
189 Recombinant hirudin enhances cardiac output and decreases systemic
vascular resistance during reperfusion after cardiopulmonary bypass in a
porcine model
Mikko Jormalainen, MD, Antti E. Vento, MD, PhD, Ulla Wartiovaara-Kautto, MD, PhD,
Raili Suojaranta-Ylinen, MD, PhD, O. Juhani Ra¨mo¨, MD, PhD, and Jari Peta¨ja¨, MD, PhD,
Helsinki, Finland
R-hirudin effectively inhibited thrombin activity and postreperfusion thrombin formation.
Postischemia left ventricular dysfunction was significantly attenuated and reperfusion-induced
increase in systemic vascular resistance was decreased in animals receiving r-hirudin.
Consequently, r-hirudin inhibited the deterioration of intestinal microcapillary perfusion
observed in the control group during reperfusion.
197 Platelet activation and aggregation profile in prolonged external ventricular
support
Re´mi Houe¨l, MD, Elisabeth Mazoyer, PharmD, Bernadette Boval, PharmD, Mathias Kirsch,
MD, Emmanuelle Verme`s, MD, Ludovic Drouet, PharmD, and Daniel Y. Loisance, MD, Cre´teil
and Paris, France
During prolonged external mechanical support, constant platelet activation and activability were
observed despite aspirin treatment. This was concomitant with a persistent inflammatory state
and endothelial activation.
203 Ischemic preconditioning or heat shock pretreatment ameliorates neuronal
apoptosis following hypothermic circulatory arrest
Chi-Hsiao Yeh, MD, Yao-Chang Wang, MD, Yi-Cheng Wu, MD, Yu-Min Lin, and
Pyng Jing Lin, MD, Keelung, Taiwan
Ischemic preconditioning can attenuate the neuronal apoptosis that causes neuronal injury seen
after hypothermic circulatory arrest (HCA). Heat shock pretreatment can also attenuate neuronal
apoptosis after HCA. However, the level of heat shock protein expression between these 2
approaches was different.
211 Can extra protamine eliminate heparin rebound following cardiopulmonary
bypass surgery?
Kevin H. T. Teoh, MD, Edward Young, PhD, Mary Helen Blackall, RN, Robin S. Roberts,
MTech, and Jack Hirsh, MD, Hamilton, Ontario, Canada
We performed a randomized study to determine whether additional protamine sulphate
administered postoperatively could eliminate heparin rebound and reduce bleeding in patients
having cardiopulmonary bypass surgery. The extra protamine was able to virtually abolish
heparin rebound and reduce postoperative bleeding, but the magnitude was insufficient to alter
transfusion requirements.
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